Walleye Trading
ONCS

Walleye Trading’s OncoSec Medical Incorporated ONCS Stock Holding History

Walleye Trading’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4
Closed -$2K – 6085
2015
Q4 		$2K Buy
+4
New +$3.01K ﹤0.01% 5115

Other funds holding ONCS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Walleye Trading's ONCS Position: Q1 2016 in Review

Walleye Trading sold out of OncoSec Medical Incorporated (ONCS) in Q1 2016, closing a stake of 4 shares — an estimated $2K sold.

Walleye Trading first reported a position in ONCS in Q4 2015 and held it in 1 quarter. The position peaked at $2K in Q4 2015. 20 funds tracked by Wall St. Rank hold ONCS as of Q1 2016.

  • Walleye Trading reported no remaining OncoSec Medical Incorporated position as of Q1 2016 after selling out during the quarter.
  • Walleye Trading sold 4 OncoSec Medical Incorporated shares in Q1 2016, an estimated $2K.
  • Walleye Trading first reported a position in OncoSec Medical Incorporated in Q4 2015 and held it in 1 quarter.
  • Walleye Trading's OncoSec Medical Incorporated position peaked at $2K in Q4 2015.
  • 20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2016.

Based on Walleye Trading's 13F filing for Q1 2016, filed 16 May 2016.